Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations
Aurinia Pharmaceuticals reported Q4 earnings of 1 cent per share, beating estimates, with LUPKYNIS sales up 36%. read more
Aurinia Pharmaceuticals reported Q4 earnings of 1 cent per share, beating estimates, with LUPKYNIS sales up 36%. read more
eBay reports Q4 results, soft Q1 revenue guidance. Analysts revise price targets on the stock. Latest Ratings for EBAY Date Firm Action From To Mar 2022 Benchmark Maintains Buy Mar 2022 Piper Sandler Maintains Overweight Feb 2022 Susquehanna Maintains Neutral View More Analyst Ratings for EBAY View the Latest Analyst Ratings read more
Jeff Bezos is sending his fiancée Lauren Sanchez, musician Katy Perry and an all-woman crew to space on Blue Origin’s next space flight. read more
Amazon announced Ocelot, its quantum computing chip that can reduce costs by up to 90%. Microsoft and Google also made advancements in quantum technology. read more
Palantir Technologies has been on a rollercoaster, surging over 268% in the past year but down 16% in the past week due to insider selling. Technicals show mixed signals, with potential for bullish momentum. read more
The cannabis industry is particularly vulnerable to cyberattacks due to regulatory burdens, and limited access to mainstream banking services. read more
Nvidia analysts break down the highlights from the company’s fourth quarter and why they’re bullish on the company’s future. Latest Ratings for NVDA Date Firm Action From To Mar 2022 Goldman Sachs Reinstates Neutral Feb 2022 Summit Insights Group Downgrades Buy Hold Feb 2022 Mizuho Maintains Buy View More Analyst Ratings for NVDA View the…
Wall Street is digesting a slew of economic data Thursday following updates on pending home sales, jobless claims and Q4 GDP estimates. Here’s a look at the data and how the markets are reacting. read more
AMD stock plunges as Nvidia dominates AI chip race. Technicals signal more downside, but fundamentals remain strong. Analysts have bullish outlook. read more